Human parvovirus 4 infection, Cameroon
Autor: | Peter Simmonds, Myriam Lavoie, Oliver G. Pybus, Yacouba Foupouapouognigni, Colin P. Sharp, Christopher Pennington, Jacques Pépin, Richard Njouom |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2016 |
Předmět: |
Male
Epidemiology lcsh:Medicine human parvovirus 4 medicine.disease_cause Cohort Studies Parvovirus 0302 clinical medicine Seroepidemiologic Studies Prevalence Cameroon Aged 80 and over 0303 health sciences biology Coinfection Dispatch Hepatitis C Middle Aged 3. Good health Infectious Diseases Streptomycin epidemiology Female medicine.drug Cohort study Microbiology (medical) PARV4 Hepatitis C virus 030231 tropical medicine lcsh:Infectious and parasitic diseases Injections Parvoviridae Infections 03 medical and health sciences human partetravirus medicine Seroprevalence Humans lcsh:RC109-216 viruses 030304 developmental biology Aged business.industry lcsh:R medicine.disease biology.organism_classification Virology Logistic Models Immunology Multivariate Analysis business |
Zdroj: | Lavoie, M, Sharp, C, Pepin, J, Pennington, C, Foupouapouognigni, Y, Pybus, O G, Njouom, R & Simmonds, P 2012, ' Human parvovirus 4 infection, Cameroon ', Emerging Infectious Diseases, vol. 18, no. 4, pp. 680-683 . https://doi.org/10.3201/eid1804.110628 Emerging Infectious Diseases Emerging Infectious Diseases, Vol 18, Iss 4, Pp 680-683 (2012) |
DOI: | 10.3201/eid1804.110628 |
Popis: | In a post hoc analysis of samples collected in 2009, we determined seroprevalence of parvovirus 4 (PARV4) among elderly Cameroonians. PARV4 seropositivity was associated with receipt of intravenous antimalarial drugs, intramuscular streptomycin, or an intramuscular contraceptive, but not hepatitis C virus seropositivity. Findings suggest parenteral acquisition of some PARV4 infections. |
Databáze: | OpenAIRE |
Externí odkaz: |